The healthcare industry has been transformed by advances in biotechnology, resulting in improved health outcomes. Central to this has been advances in medical diagnostics that can both monitor patients as well as provide actionable data at the point-of-care. However, further improvements are needed to maximize the utility of diagnostics at times where acute care may be required, such as when individuals are unstable after experiencing physical trauma. When medical resources are limited, the ability to rapidly and effectively triage patients that have experienced trauma is critical to maximizing health outcomes. Notably, individuals that have experienced significant trauma can degrade quickly. Therefore, continuous monitoring approaches are needed that can provide critical biometric and biomarker information that will enable updating of the triage in real-time.At present time, patients are assessed continuously using biometric monitoring. However, biometrics are often a lagging indicator to biochemical markers, and thus while easier to measure, less informative. Currently, the ISTAT-8 is a point-of-care unit to perform an automated, rapid biochemical panel that can assess the patient’s ability to maintain homeostasis by monitoring eight biomarkers. However, the ISTAT-8 captures biochemical data only at a point in time instead of continuously; this is a drawback, as the health of patients who have undergone trauma can improve or deteriorate rapidly. Therefore, a continuous biochemical monitoring solution is needed to allow for triage to happen in real-time.Advances in biotechnology have for the first time made real-time biochemical sensing a reality. Unfortunately, commercial continuous biochemical sensors to-date are limited to subcutaneous continuous glucose monitors (CGMs). CGMs monitor glucose concentrations in the interstitial fluid (ISF), which strongly correlates to blood values. While the CGM is now commonly used, the current devices are not easily multiplexed. Therefore, a scalable, easy to insert system is needed to perform multiplexed measurements; microneedle-based platforms have the promise to enable sensing in the ISF leveraging five or more distinct sensors.Here we present a solid-state platform that can enable multiplexed sensing leveraging hollow, wicking microneedles in fluidic contact with solid-state electrodes. Our approach leverages optimized sensor formulations and electrode materials fabricated onto a printed circuit board (PCB). The putative sensor array can be produced in a modular fashion leveraging scalable technologies and processes. Notably, this talk focuses on methods and approaches to fabricate an array of solid-state sensors that are capable of detecting ions and metabolites over extended periods (> 1 week) and can be readily integrated with microneedles for sensing interstitial fluid.
Read full abstract